During the past decade, Sakurabashi Watanabe Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sakurabashi Watanabe Hospital" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "NewAmsterdam Pharma" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sakurabashi Watanabe Hospital" #1 collaborator was "Guidant Corporation" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sakurabashi Watanabe Hospital" are "Coronary Artery Disease" (5 trials), "Heart Failure" (5 trials), "Atrial Fibrillation" (4 trials), "Angina Pectoris" (2 trials) and "Arrhythmias, Cardiac" (2 trials). Many other conditions were trialed in "Sakurabashi Watanabe Hospital" in a lesser frequency.

Most popular intervention types in "Sakurabashi Watanabe Hospital" are "Drug" (10 trials), "Device" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (2 trials), "Dabigatran Etexilate 150mg" (2 trials), "Obicetrapib" (2 trials), "Placebo" (2 trials) and "ABSORB GT1 BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sakurabashi Watanabe Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Sakurabashi Watanabe Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sakurabashi Watanabe Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sakurabashi Watanabe Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".